Valeant Bonds Trade Higher, Despite Skepticism

Associated Press Appetite for the debt of Valeant Pharmaceuticals (VRX) increased after the pharmaceutical company sealed its $11 billion deal for Salix Pharmaceuticals (SLXP) on Monday. Valeant upped its all-cash bid to $173 a share up from $158. Rival Endo International (ENDP) withdrew its cash and stock bid of $175 per share. Last week, despite [...]